AU7966494A - Electrophilic peptide analogs as inhibitors of trypsin-like enzymes - Google Patents
Electrophilic peptide analogs as inhibitors of trypsin-like enzymesInfo
- Publication number
- AU7966494A AU7966494A AU79664/94A AU7966494A AU7966494A AU 7966494 A AU7966494 A AU 7966494A AU 79664/94 A AU79664/94 A AU 79664/94A AU 7966494 A AU7966494 A AU 7966494A AU 7966494 A AU7966494 A AU 7966494A
- Authority
- AU
- Australia
- Prior art keywords
- trypsin
- enzymes
- inhibitors
- peptide analogs
- electrophilic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000004190 Enzymes Human genes 0.000 title 1
- 108090000790 Enzymes Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 230000001810 trypsinlike Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
- C07F9/53—Organo-phosphine oxides; Organo-phosphine thioxides
- C07F9/5325—Aromatic phosphine oxides or thioxides (P-C aromatic linkage)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13325193A | 1993-10-07 | 1993-10-07 | |
US133251 | 1993-10-07 | ||
US13944593A | 1993-10-20 | 1993-10-20 | |
US139445 | 1993-10-20 | ||
PCT/US1994/011280 WO1995009634A1 (fr) | 1993-10-07 | 1994-10-06 | Analogues peptidiques electrophiles servant d'inhibiteurs a des enzymes apparentees a la trypsine |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7966494A true AU7966494A (en) | 1995-05-01 |
Family
ID=26831202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU79664/94A Abandoned AU7966494A (en) | 1993-10-07 | 1994-10-06 | Electrophilic peptide analogs as inhibitors of trypsin-like enzymes |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0724446A4 (fr) |
AU (1) | AU7966494A (fr) |
CA (1) | CA2174314C (fr) |
IL (1) | IL111175A0 (fr) |
WO (1) | WO1995009634A1 (fr) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL109319A0 (en) * | 1993-04-27 | 1994-07-31 | Du Pont Merck Pharma | Amidino and guanidino substituted boronic acid compounds |
US5885967A (en) * | 1994-03-04 | 1999-03-23 | Eli Lilly And Company | Antithrombotic agents |
CA2143533A1 (fr) * | 1994-03-04 | 1995-09-05 | Kenneth D. Kurz | Agents antithrombotiques |
US5705487A (en) * | 1994-03-04 | 1998-01-06 | Eli Lilly And Company | Antithrombotic agents |
US5726159A (en) * | 1994-03-04 | 1998-03-10 | Eli Lilly And Company | Antithrombotic agents |
ZA951618B (en) * | 1994-03-04 | 1996-08-27 | Lilly Co Eli | Antithrombotic agents |
US5602101A (en) * | 1994-03-04 | 1997-02-11 | Eli Lilly And Company | Antithrombotic agents |
US5707966A (en) * | 1994-03-04 | 1998-01-13 | Eli Lilly And Company | Antithrombotic agents |
FR2721611B1 (fr) * | 1994-06-22 | 1996-09-27 | Adir | Nouveaux dérivés peptidiques de l'acide boronique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent . |
US5710130A (en) * | 1995-02-27 | 1998-01-20 | Eli Lilly And Company | Antithrombotic agents |
US5914319A (en) * | 1995-02-27 | 1999-06-22 | Eli Lilly And Company | Antithrombotic agents |
US6022861A (en) * | 1995-06-07 | 2000-02-08 | Cor Therapeutics, Inc. | Ketoheterocyclic inhibitors of factor Xa |
US5721214A (en) * | 1995-06-07 | 1998-02-24 | Cor Therapeutics, Inc. | Inhibitors of factor Xa |
US6069130A (en) | 1995-06-07 | 2000-05-30 | Cor Therapeutics, Inc. | Ketoheterocyclic inhibitors of factor Xa |
US5919765A (en) * | 1995-06-07 | 1999-07-06 | Cor Therapeutics, Inc. | Inhibitors of factor XA |
US6046169A (en) * | 1995-06-07 | 2000-04-04 | Cor Therapeutics, Inc. | Inhibitors of factor XA |
US6211154B1 (en) | 1995-06-07 | 2001-04-03 | Cor Therapeutics, Inc. | Ketoheterocyclic inhibitors of factor Xa |
US5952306A (en) * | 1996-01-16 | 1999-09-14 | Merck & Co., Inc. | Integrin receptor antagonists |
US6245743B1 (en) | 1996-06-05 | 2001-06-12 | Cor Therapeutics, Inc. | Inhibitors of factor Xa |
EP0970062A2 (fr) | 1997-03-13 | 2000-01-12 | Smithkline Beecham Plc | Derives de pyrrolidine et thiazole aux proprietes inhibant la beta-lactamase metallique |
US6294549B1 (en) | 1997-07-23 | 2001-09-25 | Merck & Co., Inc. | Method for eliciting an αvβ5 or dual αvβ3/αvβ5 antagonizing effect |
WO2001007407A1 (fr) * | 1999-07-26 | 2001-02-01 | Bristol-Myers Squibb Pharma Company | Inhibiteurs lactame de la protease ns3 du virus de l'hepatite c |
US7122627B2 (en) | 1999-07-26 | 2006-10-17 | Bristol-Myers Squibb Company | Lactam inhibitors of Hepatitis C virus NS3 protease |
PL376535A1 (pl) | 2002-09-09 | 2006-01-09 | Trigen Limited | Sole kwasu boronowego i ich zastosowanie w leczeniu zakrzepicy |
US7112572B2 (en) | 2002-09-09 | 2006-09-26 | Trigen Limited | Multivalent metal salts of boronic acids |
US7223745B2 (en) | 2003-08-14 | 2007-05-29 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
US7576206B2 (en) | 2003-08-14 | 2009-08-18 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
US7417040B2 (en) | 2004-03-01 | 2008-08-26 | Bristol-Myers Squibb Company | Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 |
US7468383B2 (en) | 2005-02-11 | 2008-12-23 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
US7727978B2 (en) | 2006-08-24 | 2010-06-01 | Bristol-Myers Squibb Company | Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors |
US8119658B2 (en) | 2007-10-01 | 2012-02-21 | Bristol-Myers Squibb Company | Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
CA2707549A1 (fr) * | 2007-12-03 | 2009-06-11 | Itzik Harosh | Inhibiteurs boropeptidiques de l'enterokinase et leurs utilisations dans le traitement de l'obesite, de la surcharge ponderale et/ou des maladies associees avec un metabolisme anormal des lipides |
RU2010142655A (ru) * | 2008-03-19 | 2012-04-27 | Ауриммед Фарма, Инк. (Us) | Соединение, пригодное для лечения болезней и нарушений центральной нервной системы, и способ его получения |
US10793515B2 (en) | 2008-03-19 | 2020-10-06 | Aurimmed Pharma, Inc. | Compounds advantageous in the treatment of central nervous system diseases and disorders |
CN104710327B (zh) * | 2008-03-19 | 2018-09-07 | 奥里梅德制药公司 | 有益于治疗中枢神经系统疾病和病症的化合物 |
WO2011087822A1 (fr) | 2009-12-22 | 2011-07-21 | Cephalon, Inc. | Inhibiteurs du protéasome et leurs procédés de préparation, d'épuration et d'utilisation |
KR101207742B1 (ko) * | 2010-10-14 | 2012-12-03 | 포항공과대학교 산학협력단 | 라벨링제 및 이를 이용한 아미노산 서열 및 단백질 다중 정량 동시 분석방법 |
CN103228621B (zh) * | 2010-08-23 | 2016-06-15 | 浦项工科大学校产学协力团 | 标记试剂以及利用其的多肽和蛋白的测序及定量方法 |
JP6129203B2 (ja) | 2011-12-22 | 2017-05-17 | アレス トレーディング ソシエテ アノニム | α−アミノボロン酸誘導体、選択性免疫プロテアソーム阻害剤 |
JP6835711B2 (ja) * | 2014-10-01 | 2021-02-24 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | ボロン酸誘導体 |
ES2811273T3 (es) * | 2014-10-01 | 2021-03-11 | Merck Patent Gmbh | Derivados del ácido borónico |
ES2761774T3 (es) | 2014-10-01 | 2020-05-21 | Merck Patent Gmbh | Derivados del ácido borónico |
JP6896618B2 (ja) * | 2014-10-01 | 2021-06-30 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | ボロン酸誘導体 |
KR102595723B1 (ko) | 2016-06-21 | 2023-10-27 | 오리온 옵탈몰로지 엘엘씨 | 헤테로시클릭 프롤린아미드 유도체 |
EP3472151A4 (fr) | 2016-06-21 | 2020-03-04 | Orion Ophthalmology LLC | Dérivés de prolinamide carbocycliques |
US11154563B2 (en) | 2017-01-18 | 2021-10-26 | Principia Biopharma Inc. | Immunoproteasome inhibitors |
RS63666B1 (sr) * | 2017-11-16 | 2022-11-30 | Principia Biopharma Inc | Inhibitori imunoproteazoma |
WO2019099582A1 (fr) | 2017-11-16 | 2019-05-23 | Principia Biopharma Inc. | Inhibiteurs d'immunoprotéasome |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4537773A (en) * | 1983-12-05 | 1985-08-27 | E. I. Du Pont De Nemours And Company | α-Aminoboronic acid derivatives |
US5187157A (en) * | 1987-06-05 | 1993-02-16 | Du Pont Merck Pharmaceutical Company | Peptide boronic acid inhibitors of trypsin-like proteases |
EP0315574A3 (fr) * | 1987-11-05 | 1990-08-22 | Hoechst Aktiengesellschaft | Inhibiteurs de la rénine |
GB9017694D0 (en) * | 1990-08-13 | 1990-09-26 | Sandoz Ltd | Improvements in or relating to organic chemistry |
GB9024129D0 (en) * | 1990-11-06 | 1990-12-19 | Thrombosis Research Trust | Inhibitors and substrates of thrombin |
EP0503203A1 (fr) * | 1991-03-15 | 1992-09-16 | Merrell Dow Pharmaceuticals Inc. | Nouveaux inhibiteurs de la thrombine |
AU6448794A (en) * | 1993-03-24 | 1994-10-11 | Du Pont Merck Pharmaceutical Company, The | Boronic acid and ester inhibitors of thrombin |
IL109319A0 (en) * | 1993-04-27 | 1994-07-31 | Du Pont Merck Pharma | Amidino and guanidino substituted boronic acid compounds |
-
1994
- 1994-10-05 IL IL11117594A patent/IL111175A0/xx unknown
- 1994-10-06 CA CA002174314A patent/CA2174314C/fr not_active Expired - Fee Related
- 1994-10-06 EP EP94930595A patent/EP0724446A4/fr not_active Withdrawn
- 1994-10-06 WO PCT/US1994/011280 patent/WO1995009634A1/fr not_active Application Discontinuation
- 1994-10-06 AU AU79664/94A patent/AU7966494A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0724446A4 (fr) | 1998-01-07 |
IL111175A0 (en) | 1994-12-29 |
CA2174314C (fr) | 2000-04-11 |
WO1995009634A1 (fr) | 1995-04-13 |
EP0724446A1 (fr) | 1996-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7966494A (en) | Electrophilic peptide analogs as inhibitors of trypsin-like enzymes | |
AU3972697A (en) | Inhibitors of cysteine protease | |
PL314838A1 (en) | Inhibitors of bp-iv-serine protease | |
AU8875398A (en) | 1-amino-7-isoquinoline derivatives as serine protease inhibitors | |
AU5533094A (en) | Enzyme inhibitors | |
AU7922694A (en) | Dipeptide boronic acid inhibitors of trypsin-like enzymes | |
AU2805897A (en) | Inhibitors of protein farnesyltransferase | |
AU1301697A (en) | Tyrosin-derivate as alpha-v-integrin inhibitors | |
AU7127298A (en) | Serine protease inhibitors | |
AU6034296A (en) | Tricyclic inhibitors of protein farnesyltransferase | |
PL323710A1 (en) | Reversible inhibitors of cysteinic protease | |
AU3479593A (en) | Peptidyl derivatives as inhibitors of interleukin-1beta converting enzyme | |
PL328665A1 (en) | Inhibitors of serinic protease | |
AU1877597A (en) | Serine protease inhibitors | |
AU7139598A (en) | Protease inhibitors | |
AU5913190A (en) | Peptidyl aminodiol renin inhibitors | |
AU2277597A (en) | New inhibitors of sh2-mediated processes | |
AU6877998A (en) | Dipeptide inhibitors of protein farnesyltransferase | |
AU9624398A (en) | Pyrrolopyrrolidine derivatives and their use as serine protease inhibitors | |
AU1287100A (en) | Peptide inhibitor of browman-birk type | |
AU4672996A (en) | Serine protease inhibitors | |
AU6855594A (en) | 9-deazahypoxanthines as pnp inhibitors | |
AU9300298A (en) | Protease inhibitors | |
AU2126895A (en) | Parasite enzyme inhibitors and substrate analogs | |
AU2545697A (en) | Novel uses of phospholipase c inhibitors |